๐Ÿ•ต๏ธ Corbus Pharmaceuticals Holdings, Inc. ($CRBP)

SEC insider & ownership activity, last 12 months ยท CIK 1595097 ยท every row links its SEC filing

Over the last 12 months insiders sold $1.4M against $101K of open-market buying. Cohen Yuval sold $579K through a 10b5-1 trading plan in 3 lots (Octโ€“Feb). 1 planned sale is pending, the largest $212K (Smethurst Dominic). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net -$714K Nov 2025: net +$0 Dec 2025: net -$344K Jan 2026: net +$0 Mar 2026: net -$51K Mar 2026: net -$51K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$28K Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

1 buyer, $101K (2 lots) ยท 8 sellers, $1.4M (14 lots)

InsiderBuysBoughtSellsSoldLast
Cohen Yuval0โ€“ 3$579KFeb 13, 2026
Cormorant Asset Management, LP0โ€“ 1$344KDec 11, 2025
Sean F. Moran0โ€“ 2$258KFeb 13, 2026
Nishant C. Saxena2$101K 0โ€“Jun 3, 2026
Smethurst Dominic0โ€“ 2$77KMar 2, 2026
Altmeyer Anne0โ€“ 2$41KJun 10, 2026
Jenkins John Kenneth0โ€“ 1$38KJun 10, 2026
Hodgson Ian0โ€“ 2$26KFeb 17, 2026
Kung Winston0โ€“ 1$16KJun 10, 2026

5%+ holders

HolderStakeClassScheduleEvent
Cormorant Asset Management, LP 13.4% 13GDec 15, 2025 filing โ†—
Chen Bihua 13.4% 13GDec 15, 2025 filing โ†—
Bihua Chen 12.8% 13GNov 14, 2025 filing โ†—
Aberdeen Group PLC 7.5% 13GJan 16, 2026 filing โ†—
Abrdn Inc. 7.5% 13GJan 16, 2026 filing โ†—
Blackrock, Inc. 5.9% 13GJul 27, 2026 filing โ†—
Orbimed Capital LLC 5.9% 13GFeb 14, 2025 filing โ†—
Kenneth Griffin 5.3% 13GNov 12, 2025 filing โ†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Smethurst Dominic$212KJul 27, 2026 filing โ†—
Smethurst Dominic$51KMar 2, 2026 filing โ†—
Cohen Yuval$813KFeb 13, 2026 filing โ†—
Cohen Yuval$470KOct 24, 2025 filing โ†—
Sean F. Moran$221KOct 24, 2025 filing โ†—

Material events (8-K)

ItemEvent date
Material agreement (1.01)Jul 2, 2026 filing โ†—
Reg FD disclosure (7.01)Jul 2, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 2, 2026 filing โ†—
Reg FD disclosure (7.01)May 26, 2026 filing โ†—
Other events (8.01)May 26, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 26, 2026 filing โ†—
Material agreement (1.01)May 19, 2026 filing โ†—
Officer/director changes (5.02)May 19, 2026 filing โ†—
Reg FD disclosure (7.01)May 19, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 19, 2026 filing โ†—
Officer/director changes (5.02)May 13, 2026 filing โ†—
Shareholder vote (5.07)May 13, 2026 filing โ†—
Reg FD disclosure (7.01)May 13, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 13, 2026 filing โ†—
Earnings (2.02)May 12, 2026 filing โ†—
Reg FD disclosure (7.01)May 12, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 12, 2026 filing โ†—
Officer/director changes (5.02)Apr 15, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 15, 2026 filing โ†—
Reg FD disclosure (7.01)Apr 14, 2026 filing โ†—
Other events (8.01)Apr 14, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 14, 2026 filing โ†—
Officer/director changes (5.02)Apr 1, 2026 filing โ†—
Reg FD disclosure (7.01)Apr 1, 2026 filing โ†—
Other events (8.01)Apr 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 1, 2026 filing โ†—
Earnings (2.02)Mar 9, 2026 filing โ†—
Reg FD disclosure (7.01)Mar 9, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 9, 2026 filing โ†—
Reg FD disclosure (7.01)Feb 25, 2026 filing โ†—